Header Logo

Connection

WILLIAM PEACOCK to Dyspnea

Back to Details
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Dyspnea.
WILLIAM PEACOCK
Connection Strength
3.459
Dyspnea
  1. ST2 in emergency department patients with noncardiac dyspnea. Acad Emerg Med. 2013 Nov; 20(11):1207-10.
    View in: PubMed
    Score: 0.401
  2. Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA). J Card Fail. 2012 Mar; 18(3):226-32.
    View in: PubMed
    Score: 0.353
  3. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
    View in: PubMed
    Score: 0.345
  4. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease. Ann Emerg Med. 2008 Jan; 51(1):25-34.
    View in: PubMed
    Score: 0.264
  5. Acoustic cardiography in the differential diagnosis of dyspnea. Congest Heart Fail. 2006 Jul-Aug; 12 Suppl 1:41-3.
    View in: PubMed
    Score: 0.241
  6. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006 Apr; 13(4):365-71.
    View in: PubMed
    Score: 0.236
  7. Remote dielectric sensing for detecting pulmonary edema in the emergency department. Am J Emerg Med. 2022 05; 55:11-15.
    View in: PubMed
    Score: 0.179
  8. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 05; 8(5):415-422.
    View in: PubMed
    Score: 0.157
  9. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The?ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.136
  10. Is there a clinically meaningful difference in patient reported dyspnea in acute heart failure? An analysis from URGENT Dyspnea. Heart Lung. 2017 Jul - Aug; 46(4):300-307.
    View in: PubMed
    Score: 0.128
  11. Considerations for initial therapy in the treatment of acute heart failure. Crit Care. 2015 Nov 10; 19:399.
    View in: PubMed
    Score: 0.115
  12. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J. 2013 Aug; 30(8):633-7.
    View in: PubMed
    Score: 0.093
  13. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail. 2012 Jan; 14(1):22-31.
    View in: PubMed
    Score: 0.088
  14. Japanese-Western consensus meeting on biomarkers. Int Heart J. 2011; 52(5):253-65.
    View in: PubMed
    Score: 0.082
  15. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med. 2011 Oct; 29(8):924-31.
    View in: PubMed
    Score: 0.080
  16. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010 May 11; 55(19):2062-76.
    View in: PubMed
    Score: 0.079
  17. Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail. 2009 Nov; 11(11):1043-9.
    View in: PubMed
    Score: 0.076
  18. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther. 2008 Jul-Aug; 15(4):299-303.
    View in: PubMed
    Score: 0.069
  19. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J. 2008 Mar; 29(6):816-24.
    View in: PubMed
    Score: 0.068
  20. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007 Aug 14; 50(7):607-13.
    View in: PubMed
    Score: 0.065
  21. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea. J Card Fail. 2006 May; 12(4):286-92.
    View in: PubMed
    Score: 0.060
  22. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. J Emerg Med. 2005 Oct; 29(3):243-52.
    View in: PubMed
    Score: 0.057
  23. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study. J Card Fail. 2022 02; 28(2):226-233.
    View in: PubMed
    Score: 0.043
  24. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 2013 Jun; 1(3):192-9.
    View in: PubMed
    Score: 0.024
  25. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. Ann Emerg Med. 2009 Jun; 53(6):748-57.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.